Clinical Trial

Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia

Name: Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia — clinical trial record (NCT07572656)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Due to limited data regarding preeclampsia from the local population, the debate is still ongoing in the study setting. Hence, the current study was planned to compare the efficacy of labetalol and hydralazine for the treatment of hypertension in patients with severe preeclampsia.

Trial Details

NCT Number	NCT07572656
Lead Sponsor	Muhammad Aamir Latif
Conditions	Preeclampsia
Enrollment	132 participants
Start Date	2024-05-01
Primary Completion	2024-10-31 (estimated)
Study Completion	2024-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-07